{"id":50503,"date":"2026-08-04T05:27:00","date_gmt":"2026-08-04T03:27:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=e2c4d6b21f92b65bf12b53646ef99ac2"},"modified":"2026-08-04T05:27:00","modified_gmt":"2026-08-04T03:27:00","slug":"hca-shareholder-alert-hca-healthcare-inc-investors-encouraged-to-contact-kirby-mcinerney-llp-about-potential-securities-laws-violations","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=50503","title":{"rendered":"HCA SHAREHOLDER ALERT: HCA Healthcare, Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations"},"content":{"rendered":"

NEW YORK--(BUSINESS WIRE)--$HCA<\/a> #classaction<\/a>--The law firm of Kirby McInerney LLP<\/a> reminds investors of its investigation on behalf of HCA Healthcare, Inc. (\u201cHCA Healthcare\u201d or the \u201cCompany\u201d) (NYSE: HCA) investors concerning the Company\u2019s and\/or members of its senior management\u2019s possible violation of the federal securities laws or other unlawful business practices.<\/p>

[LEARN MORE ABOUT THE INVESTIGATION<\/a>]<\/p>

What Happened?<\/b><\/p>

On July 14, 2026, HCA Healthcare issued a press release reporting its preliminary financial and operating results for the second quarter of 2026. Among other items, HCA Healthcare sharply lowered its full-2026 profit guidance, citing an unfavorable shift in the Company\u2019s payer mix, driven by an increase in uninsured volume\u2014primarily due to patients who had lost coverage on health insurance exchanges\u2014which impacted revenue by approximately $400 million in the quarter. The Company lowered its forecast for 2026 earnings to between $28.70 and $30.50 a share and narrowed its revenue target to $77 billion to $79.5 billion from a prior $76.5 billion to $80 billion range. Adjusted earnings before interest, taxes, depreciation and amortization are targeted at between $15.4 billion and $16.1 billion, where HCA Healthcare previously anticipated $15.55 billion to $16.45 billion.<\/p>

On this news, HCA Healthcare\u2019s stock price fell $27.14 per share, or 6.95%, to close at $363.60 per share on July 14, 2026.<\/p>

What Should I Do?<\/b><\/p>

At this stage, no lawsuit has been filed. The investigation is ongoing to determine whether claims may be brought under federal securities laws. Click here to learn more about securities class actions.<\/a><\/p>

If you purchased or otherwise acquired HCA Healthcare securities, have information, or would like to learn more about this investigation, please contact Lauren Molinaro<\/a> of Kirby McInerney LLP<\/a> by email at investigations@kmllp.com<\/a>, or fill out the contact form below, to discuss your rights or interests with respect to these matters at no cost.<\/p>

[LEARN MORE ABOUT THE INVESTIGATION<\/a>]<\/p>

Kirby McInerney LLP<\/a> is a New York-based plaintiffs\u2019 law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm\u2019s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP\u2019s website<\/a>.<\/p>

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.<\/p><\/a><\/a> Contacts<\/b>

Kirby McInerney LLPLauren Molinaro, Esq.212-699-1171https:\/\/www.kmllp.com<\/a>https:\/\/securitiesleadplaintiff.com\/<\/a>investigations@kmllp.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"

NEW YORK–(BUSINESS WIRE)–$HCA #classaction–The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of HCA Healthcare, Inc. (\u201cHCA Healthcare\u201d or the \u201cCompany\u201d) (NYSE: HCA) investors concerning the Company\u2019s and\/or members…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-50503","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/50503","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=50503"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/50503\/revisions"}],"predecessor-version":[{"id":50504,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/50503\/revisions\/50504"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=50503"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=50503"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=50503"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}